Stocks in news: JSW Energy, IDFC First Bank, Zydus Life, Alkem Labs, Tata Elxsi

JSW Energy's board to meet on April 2 to consider a proposal for raising of funds through the issuance of eligible securities of the company by way of private offerings or on a preferential allotment basis.

Indian markets showed strength amid mixed global cues and gained over half a percent on Wednesday. In today's trade, shares of , , , , among others will be in focus due to various news developments.

JSW Energy
JSW Energy's board to meet on April 2 to consider a proposal for raising of funds through the issuance of eligible securities of the company by way of private offerings or on a preferential allotment basis.

CDSL
Standard Chartered Bank has sold its entire stake and exited Central Depository Services (India) Ltd through bulk deals on Wednesday.

IDFC First Bank
Private equity major Warburg Pincus is likely to exit IDFC First Bank by selling its entire 2.3% stake in the lender through block deals on Thursday, according to reports.

Zydus Life
Zydus Lifesciences said the US health regulator has issued a Form-483 with four observations following the inspection of its Ahmedabad-based SEZ Onco Injectable manufacturing plant.

Bank of Maharashtra
The union government has appointed Nidhu Saxena as Managing Director and Chief Executive Officer of Bank of Maharashtra.

Alkem Labs
USFDA had conducted an inspection at the company' Baddi manufacturing facility and issued Form 483 with 10 observations.


Emami has entered into a share purchase agreement with the founder and other shareholders of Brillare for acquiring the remaining stake of 4.64% of that company.

Tata Elxsi
Tata Elxsi has partnered with Drager to advance critical care innovation in India. Under the partnership, Drager will establish its offshore development center (ODC) at Tata Elxsi's facility in Pune.

Chalet Hotels
Chalet Hotels has launched a qualified institutional placement (QIP) issue to raise up to Rs 1,200 crore. The floor price is set at Rs 775 per share.

Dr Reddy’s
Dr Reddy’s has signed an exclusive distribution agreement with Sanofi Healthcare India to promote and distribute the vaccine brands of the company.

Source: Stocks-Markets-Economic Times

Последние публикации
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Анализ рынка Как повлият завтра отчет NFP на курс доллара США?